Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1976-02-05
1982-09-21
Fagelson, Anna P.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424 89, 424 93, A61K 3105
Patent
active
043507077
ABSTRACT:
Inactivation of, and treatment of diseases caused by, lipid containing viruses, particularly herpes simplex virus, with butylated hydroxytoluene.
REFERENCES:
patent: 2081284 (1937-05-01), Stockelbach
Snipes, Science, vol. 188, Apr. 4, 1975; pp. 64-66.
Cupp, Antimicrobial Agents & Chemotherapy, vol. 8; No. 6, Dec. 1975, pp. 698-705.
Emanuel, Chem. Abs., vol. 52, 1958, p. 20643c.
Kajimoto, Chem. Abs., vol. 61, 1964, pp. 13797c-13797j.
Sands, Chem. Abs., vol. 61, 1964, p. 989j.
Dolyagin, Chem. Abs., vol. 74, 1971, No. 20492t.
De Navarre, The Chem. & Mfg. of Cosmetics, D. Van Nostrand Co., N.Y., 2nd Ed., vol. I, 1962, pp. 300, 305-313.
Keith Alec D.
Snipes Wallace
Fagelson Anna P.
Research Corporation
LandOfFree
Inactivation of lipid containing viruses with butylated hydroxyt does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inactivation of lipid containing viruses with butylated hydroxyt, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inactivation of lipid containing viruses with butylated hydroxyt will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2076344